Recursion Pharmaceuticals' AI-driven Recursion OS platform shows strong potential but has yet to demonstrate a clear ...

Recursion can feel like magic until you understand its simple rules: a base case to stop, and a recursive call to repeat. By breaking problems into smaller versions of themselves, recursion makes ...

Recursion is more than a coding trick—it’s a powerful way to simplify complex problems in Python. From elegant tree traversals to backtracking algorithms, mastering recursion opens the door to cleaner ...

A new AI startup has grabbed global attention with a bold claim. Founded just a few months ago, this British AI lab has ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.

LOS GATOS, Calif.-- (BUSINESS WIRE)--Apr 23, 2026-- ...

Engineering, procurement, and construction companies (EPC) are positioned to benefit as hyperscaler capital expenditures for artificial intelligence infrastructure accelerate, according to Barclays.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Explore the 10 best generative AI courses to take in 2026, with options for hands-on training, certifications, and practical ...